Cancer Therapy encompasses a multifaceted approach to combat the complexities of cancer, utilizing various strategies to target and control malignant cells. Surgical interventions involve the removal of tumors, while chemotherapy employs potent drugs to disrupt the rapid division of cancer cells throughout the body. Radiation therapy utilizes focused radiation to damage cancer cell DNA, impeding their ability to proliferate. Immunotherapy harnesses the body's immune system to recognize and eliminate cancer cells, with approaches like checkpoint inhibitors and CAR-T cell therapy. Hormone therapy and targeted therapy specifically address hormone-dependent cancers or target molecular pathways crucial for cancer growth. Precision medicine tailors treatments based on individual genetic or molecular profiles, optimizing therapeutic outcomes. Stem cell transplants may be employed to replace diseased bone marrow. The evolving field of cancer therapy continually integrates innovative approaches, aiming for improved efficacy, reduced side effects, and personalized treatment strategies. Multidisciplinary collaboration, guided by factors like cancer type, stage, and patient health, shapes comprehensive treatment plans, reflecting the dynamic nature of cancer care and research.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy